Concept information
Preferred term
acomplia
Definition
- Acomplia is the trade name of rimonabant (generic name), which has been approved in the European Union (EU), Argentina, and Mexico for the treatment of obesity. As of March 2007, rimonabant (the proposed U.S. trade name is Zimulti) is under review by the Food and Drug Administration (FDA) and it is not yet available in the United States. [Source: Encyclopedia of Obesity; Acomplia]
Broader concept
Belongs to group
URI
https://concepts.sagepub.com/social-science/concept/acomplia
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}